HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J/Ethicon

This article was originally published in The Tan Sheet

Executive Summary

Wound care division will "phase out production and marketing of selected general wound care product lines - including eye pads, sponges, gauze pads, tapes and cleaners - in the U.S. within the next six months," firm says in July 1 letter to distributors. J&J/Ethicon instead will focus on developing drug/device combination products for advanced wound care, such as Band-Aid liquid bandage and Dermabond topical skin adhesive, which are manufactured by Closure Medical and marketed by J&J (1"The Tan Sheet" March 18, 2002, p. 19). Several Band-Aid products, such as Steri-Pad gauze pads, are affected by the phase-out, which includes 36 brands. J&J/Ethicon plans to close its manufacturing facility in Sherman, Texas by Dec. 31 and says the move will affect roughly 510 employees at the plant...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS129453

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel